You have 9 free searches left this month | for more free features.

Condition

Breast Cancer (1)

Breast Neoplasm (1)

Carcinoma, Ductal, Breast (1)

Carcinoma, Non-Small-Cell Lung (1)

Lung Cancer (1)

Non-small Cell Lung Cancer (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

G1 Therapeutics, Inc. (2)

Collaborator

Intervention

g1t38 (2)

fulvestrant (1)

osimertinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

g1t38

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC, Lung Cancer, NSCLC Trial in United States (G1T38, Osimertinib)

Completed

Carcinoma, Non-Small-Cell Lung
+2 more

G1T38
Osimertinib

Beverly Hills, California
+7 more

Sep 20, 2022

Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)

Active, not recruiting

Carcinoma, Ductal, Breast
+2 more

G1T38
Fulvestrant

Sofia, Bulgaria
+7 more

Aug 1, 2022